Back
Entrada Therapeutics Stock Price Chart
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
41
TRDA
Entrada Therapeutics
Last Price:
13.68
Seasonality Move:
13.84%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TRDA is experiencing slight selling pressure.
Entrada Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 14.74 | Sell |
| 20-day SMA: | 15.78 | Sell |
| 50-day SMA: | 16 | Sell |
| 200-day SMA: | 14.67 | Sell |
| 8-day EMA: | 14.84 | Sell |
| 20-day EMA: | 15.36 | Sell |
| 50-day EMA: | 15.56 | Sell |
| 200-day EMA: | 15 | Sell |
Entrada Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.4 | Sell |
| Relative Strength Index (14 RSI): | 37.42 | Sell |
| Chaikin Money Flow: | -37649 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.92 - 16.8) | Sell |
| Bollinger Bands (100): | (14.03 - 16.61) | Sell |
Entrada Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Entrada Therapeutics Stock
Is Entrada Therapeutics Stock a Buy?
- Entrada Therapeutics share price is 14.16 while TRDA 8-day simple moving average is 14.74, which is a Sell signal.
- The stock price of TRDA is 14.16 while Entrada Therapeutics 20-day SMA is 15.78, which makes it a Sell.
- Entrada Therapeutics 50-day simple moving average is 16.00 while TRDA share price is 14.16, making it a Sell technically.
- TRDA stock price is 14.16 and Entrada Therapeutics 200-day simple moving average is 14.67, creating a Sell signal.
TRDA Technical Analysis vs Fundamental Analysis
Sell
41
Entrada Therapeutics (TRDA)
is a Sell
Is Entrada Therapeutics a Buy or a Sell?
-
Entrada Therapeutics stock is rated a Sell
The current Entrada Therapeutics [TRDA] share price is $14.16. The Score for TRDA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Entrada Therapeutics Stock Info
Market Cap:
526.75M
Price in USD:
14.16
Share Volume:
160.01K
Entrada Therapeutics 52-Week Range
52-Week High:
18.17
52-Week Low:
10.75
Sell
41
Entrada Therapeutics (TRDA)
is a Sell
Entrada Therapeutics Share Price Forecast
-
What is the Entrada Therapeutics stock price today?
The Entrada Therapeutics stock price is 14.16 USD today. -
Will TRDA stock go up or go down?
Entrada Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Entrada Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Entrada Therapeutics is overvalued.
Is Entrada Therapeutics Stock a Buy?
- Entrada Therapeutics share price is 14.16 while TRDA 8-day exponential moving average is 14.84, which is a Sell signal.
- The stock price of TRDA is 14.16 while Entrada Therapeutics 20-day EMA is 15.36, which makes it a Sell.
- Entrada Therapeutics 50-day exponential moving average is 15.56 while TRDA share price is 14.16, making it a Sell technically.
- TRDA stock price is 14.16 and Entrada Therapeutics 200-day simple moving average is 15.00, creating a Sell signal.
Fundamental Analysis of Entrada Therapeutics
Is Entrada Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.35 per share, an increase this year of $0.68 per share, and a decrease next year of $3.79 per share.
Technical Analysis of Entrada Therapeutics
Should I short Entrada Therapeutics stock?
- TRDA Moving Average Covergence Divergence (MACD) indicator is -0.4, suggesting Entrada Therapeutics is a Sell
- Entrada Therapeutics Relative Strength Index (RSI) is 37.42, which suggest Entrada Therapeutics is oversold
- The Bollinger Bands (25) for Entrada Therapeutics is (14.92 - 16.8), which suggest Entrada Therapeutics is a Sell
- The Bollinger Bands (100) for Entrada Therapeutics is (14.03 - 16.61), which suggest Entrada Therapeutics is a Sell
* Entrada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.